Literature DB >> 10027803

Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma.

R E Kuntz.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10027803     DOI: 10.1161/01.cir.99.7.847

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  12 in total

Review 1.  Revascularization strategies in patients with diabetes: evolving concepts.

Authors:  J J Brennan; H S Cabin
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Percutaneous coronary intervention in diabetics: time to consider "intimal remodelling therapy"?

Authors:  P F Ludman
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

Review 3.  Optimal treatment for coronary artery disease in patients with diabetes: percutaneous coronary intervention, coronary artery bypass graft, and medications.

Authors:  Hiroshi Ito
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-01-12

4.  Diabetes in patients undergoing coronary artery bypass grafting. Impact on perioperative outcome.

Authors:  J Bucerius; J F Gummert; T Walther; N Doll; M J Barten; V Falk; F W Mohr
Journal:  Z Kardiol       Date:  2005-09

5.  Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with diabetes mellitus: a patient-level meta-analysis of randomized trials.

Authors:  Antoinette de Waha; Alban Dibra; Sebastian Kufner; Dietrich Baumgart; Manel Sabate; Aleardo Maresta; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2011-01-08       Impact factor: 5.460

Review 6.  The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Authors:  Robert L Frye; Malcolm R Bell; Hartzell V Schaff; Richard Holubkov; Katherine M Detre
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

7.  Comparison of bypass surgery with drug-eluting stents in diabetic patients with left main coronary stenosis.

Authors:  Xiaoxiao Zhao; Yujie Zhou; Hui Song; Like Guan; Guanbin Zheng; Zhehu Jin; Dongmei Shi; Yuzi Li; Yonghe Guo; Guo-Ping Shi; Xian Wu Cheng
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

8.  Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry.

Authors:  Anurag Polavarapu; Raghava Sarma Polavarapu; Jayesh Prajapati; Asif Raheem; Kamlesh Thakkar; Shivani Kothari; Ashok Thakkar
Journal:  Int J Vasc Med       Date:  2015-09-02

9.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary artery disease and diabetic nephropathy: a single center experience.

Authors:  Ki Sun Bae; Hyeong Cheon Park; Byung Seung Kang; Jong Won Park; Nu Ri Chon; Kyung Jin Oh; Young Won Yoon; You Sun Hong; Sung Kyu Ha
Journal:  Korean J Intern Med       Date:  2007-09       Impact factor: 3.165

10.  Influence of diabetes mellitus on heart failure risk and outcome.

Authors:  Christophe Bauters; Nicolas Lamblin; Eugène P Mc Fadden; Eric Van Belle; Alain Millaire; Pascal de Groote
Journal:  Cardiovasc Diabetol       Date:  2003-01-08       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.